Viewing nowAtorstat Tablet 20 mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

MFDS item code 201500660 · Approved 2015.02.09 · Insurance code 642706310
Improvement of hyperlipidemia; prevention of cardiovascular diseases (such as myocardial infarction and stroke)
This medication helps reduce the risk of cardiovascular diseases. In particular, it lowers the possibility of myocardial infarction and stroke in adults with risk factors for coronary artery disease and patients with type 2 diabetes. Additionally, it decreases the risks of recurrent myocardial infarction, stroke, the need for vascular intervention, heart failure hospitalization, and angina in patients who already have heart diseases. Moreover, it aids in lipid improvement by reducing total cholesterol, LDL cholesterol, Apo-B protein, and triglyceride levels while increasing HDL cholesterol levels in patients with hyperlipidemia. It is also used for cholesterol control in specific types of hyperlipidemia that do not respond effectively to diet, as well as in some pediatric patients. Therefore, this drug is used for the prevention and treatment of cardiovascular diseases and for the improvement of hyperlipidemia.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin, and continue it throughout the treatment period. This medication may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients who require a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (40 mg is for patients requiring an LDL cholesterol reduction of 45 % or more). This medication is administered once daily in a dosage range of 10 ~ 80 mg. The initial and maintenance doses of this medication should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after initiation of treatment and/or dose titration, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used at treatment initiation and to assess treatment response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dosage of this medication is 10 ~ 80 mg once daily. It should be used in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when such lipid-lowering treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: Efficacy and safety in patients aged 70 years and older are similar to those in the general adult population.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medication once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on doses of this medication greater than 20 mg in pediatric patients). Adjust the dose as appropriate for each patient according to the recommended treatment goal. Adjust the dose at intervals of 4 weeks or longer.
This medication carries a risk of muscle problems; therefore, if severe muscle pain or weakness occurs, or if creatine kinase levels rise significantly, it should be discontinued immediately. This medication should not be used in individuals with certain diseases, such as liver disease, muscle disorders, women who are pregnant or breastfeeding, and children under 10 years of age. For individuals with impaired liver or kidney functions, the elderly, and alcoholics, the risk of side effects may be increased, so careful use is necessary. Regular checks of liver function and muscle condition should be performed while taking this medication, and if any unusual symptoms occur, consult a physician immediately. Taking this medication with certain other drugs may alter its blood concentration; hence, inform your doctor or pharmacist if you are taking other medications. Women who are pregnant or may become pregnant should strictly use appropriate contraceptive methods while taking this drug, and this medication should be stopped immediately if pregnancy is confirmed. Breastfeeding women should not take this medication, and if they are currently taking it, breastfeeding should be stopped. Long-term safety in children and adolescents has not been sufficiently studied, so use in individuals under 18 years of age should be approached with caution. No specific antidote exists for overdose, and treatment should be guided by symptoms while monitoring liver function and muscle condition. This medication should be stored out of reach of children and kept in its original container, ensuring it is not transferred to another container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture, ideally at room temperature between 1 to 30 degrees Celsius. Storing it this way will maintain the medication's effectiveness.
White oval film-coated tablet
30 tablets per bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.